SNEX insider Form 4: 145 restricted shares granted, total 35,535

Rhea-AI Filing Summary

StoneX Group Inc. (SNEX) director Steven A. Kass was granted 145 restricted shares of common stock on 10/31/2025 under the Company’s Restricted Stock Program at a stated price of $0.

Following the grant, Kass beneficially owned 35,535 shares, held directly. The restricted shares vest equally on the anniversary in years one, two, and three, aligning compensation with multi-year service.

Insider Trade Summary

Net Buyer: 145 shares

Net Buy 1 txn

Insider KASS STEVEN A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Shares of Common Stock	145	$0.00	$0.00

Holdings After Transaction: Restricted Shares of Common Stock — 35,535 shares (Direct)

Footnotes (1)

1. F1. Acquired through the Company's Restricted Stock Program. Shares vest equally on anniversary in years one, two and three.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/03/2025 - 04:48 PM Learn about SEC filing dates

FAQ

What insider transaction was reported for SNEX?

Director Steven A. Kass was granted 145 restricted shares of common stock on 10/31/2025.

What was the price for the SNEX restricted share grant?

The restricted shares were recorded at $0 per share under the Company’s Restricted Stock Program.

How many SNEX shares does the insider own after the transaction?

After the grant, Kass beneficially owned 35,535 shares, held directly.

What is the vesting schedule for the SNEX restricted shares?

The 145 restricted shares vest equally on the anniversary in years one, two, and three.

What is the insider’s relationship to SNEX?

Steven A. Kass is a Director of StoneX Group Inc.

Was this a Form 4 filed by multiple reporting persons?

No. It was filed by one reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KASS STEVEN A

(Last) (First) (Middle)

230 PARK AVENUE

10TH FLOOR

(Street)

NEW YORK NY 10169

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
StoneX Group Inc. [ SNEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Restricted Shares of Common Stock(1)	10/31/2025		A		145	A	$0	35,535	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquired through the Company's Restricted Stock Program. Shares vest equally on anniversary in years one, two and three.

Remarks:

	Steven A. Kass	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.